Production Of Flavonoid, An Anti-Inflammatory Agent From Trametes lactinea by Yahaya, Yus Azila
 PRODUCTION OF FLAVONOID, AN ANTI-INFLAMMATORY AGENT FROM 
Trametes lactinea 
 
 
 
 
 
 
 
 
 
 
YUS AZILA YAHAYA 
 
 
 
 
 
 
 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
2014 
 
  
PRODUCTION OF FLAVONOID, AN ANTI-INFLAMMATORY AGENT FROM 
Trametes lactinea 
 
 
 
 
 
 
 
By 
 
 
 
YUS AZILA YAHAYA 
 
 
 
 
 
 
 
 
 
 
Thesis submitted in fulfilment of the requirements for the degree of Doctor of 
Philosophy 
 
SEPTEMBER 2014 
ii 
 
ACKNOWLEDGEMENT 
In the Name of Allah, the Most Gracious, the Most Merciful. Alhamdulillah (Praise 
to God) and Selawat (Prayer for peace and prosperity) to noble Prophet Muhammad 
SAW and upon his family and companions, the honorable followers.  
I would like to express my deep gratitude to Assoc. Prof. Dr. Mashitah Mat Don for 
the constant encouragement during the planning and development of this research 
work. Without her guidance, it is impossible for me to complete this dissertation. 
I would like to offer my special thanks to my co-supervisor, Assoc. Prof. Ahmad 
Shukri who have given his valuable guidance and technical support on this project. I 
would also like to thank to the Dean of School of Chemical Engineering USM, Prof. 
Dr. Azlina Harun @ Kamaruddin and the staffs for their help in offering the 
resources in running this project.  
Last but not least, my deepest gratitude to my husband, my mother and also my little 
daughter for their love and support. Without their love, I would not be able to face 
the toughest moment in my life for the completion of this dissertation.  
I would also like to thank everyone who assisting me throughout my project. Finally, 
indebtedness to NSF for financial support throughout my study. I pray that Allah 
grant us success in all our endeavours.  
 
Yus Azila Yahaya 
September 2014 
 
 
iii 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENT              ii 
TABLE OF CONTENTS              iii 
LIST OF TABLES               x 
LIST OF FIGURES                xv 
LIST OF PLATES               xxi 
LIST OF SYMBOLS               xxii 
LIST OF ABBREVIATIONS                         xxiv 
ABSTRAK                xxvii 
ABSTRACT                xxix 
 
CHAPTER 1-INTRODUCTION 
1.1 Research background        1 
1.2 Problem statement        8 
1.3 Research objectives        11 
1.4 Scope of study         12 
1.5 Organization of the thesis        13 
 
CHAPTER TWO-LITERATURE REVIEW 
2.1 Flavonoid, as anti-inflammatory agent      15 
      2.1.1 History of flavonoid production      15 
      2.1.2 Structure of flavonoid       17 
      2.1.3 Chemical and Physical Properties of flavonoid    19 
      2.1.4 Separation and quantification of flavonoid                20 
      2.1.5 Anti-inflammatory assays of flavonoid     22 
iv 
 
2.2 White rot fungi         23 
       2.2.1 Morphology of white rot fungi and their applications    23 
       in food and pharmaceutical industries, and environmental. 
       2.2.2 Trametes lactinea (T. lactinea)      26 
2.3 Fungi growth via fermentation process      28 
      2.3.1 Submerged fermentation (SmF)      31 
      2.3.2 Mode of submerged fermentation                 31 
           (a) Batch          31                              
(b) Fed batch         33 
            (c) Continuous         34 
2.4 Optimization of fermentation process      35 
      2.4.1. One-factor-at-a-time (OFAT) method     36 
      2.4.2 Response surface methodology (RSM)     36 
           (a) Box Behnken Design (BBD)      37 
      2.4.3 Artificial intelligence and evolutionary computing.    39 
2.5 Fermentation kinetics and modeling      40 
      2.5.1 Microbial growth        40 
(a) Monod model        40 
(b) Logistic model        42 
(c) Modified logistic model       43 
(d) Gompertz model        44 
2.5.2 Product formation        45 
(a)  Logistic-incorporated Leudeking-Piret model (LLP)   45 
(b) Modified logistic incorporated Luedeking-Piret model (MLLP)  47 
(c) Modified Gompertz model                  48 
v 
 
(d) Monod-incorporated Luedeking-Piret model (MLP)   49 
2.5.3 Substrate utilization        49 
(a) Logistic-incorporated Ludeking-Piret like Model (LLPL)   48 
(b) Modified logistic incorporated modified      51 
Leudeking-Piret model (MLMLP) 
(c) Monod-incorporated modified Ludeking-Piret model (MMLP)  51 
(d) Modified Gompertz model       52 
     2.5.4 Substrate inhibition models        53 
(a) Noncompetitive Mmodel       53 
(b) Haldane Model        53 
(c) Luong Model        54 
(d) Aiba Model         54 
2.6 Summary          55 
 
CHAPTER THREE-MATERIALS AND METHODS 
3.0 Chemicals and equipment        56 
3.1 Research flow chart        58 
3.2 Fungal strains         60 
3.3 Preparation of mycelial suspension      61 
3.4 Preparation of inoculum        62 
3.5 Screening of anti-inflammatory agent via flavonoid and enzyme             62      
inhibition assays from selected fungi  
      3.5.1 Fungi cultivation        62 
3.6 Batch extraction process        63 
vi 
 
3.7 Optimization of culture conditions for growth and flavonoid   63                                                            
production by T. lactinea in shake flask culture   
       3.7.1 Optimization using one-factor-at-a-time (OFAT) method    63 
       3.7.2 Optimization using Design of Experiment (DoE)                65 
    via Box Behnken approach       
3.8 Growth and flavonoid production of T. lactinea in stirred tank bioreactor  66      
studies           
3.9 Analytical method        68 
      3.9.1 Determination of oxygen uptake rate (OUR), oxygen transfer rate68 
               (OTR) and volume mass transfer coefficient (kLa) from bioreactor  
   fermentation process        
      3.9.2 Determination of mycelial dry weight (biomass)    70 
      3.9.3 Determination of glucose concentration     70 
      3.9.4 Determination of culture broth viscosity     70 
      3.9.5 Determination of flavonoid using UV-vis                71 
         spectrophotometer       
      3.9.6 Determination of anti-inflammatory activities via in vitro              72  
         enzyme inhibition assays    
(a) Hyaluronidase inhibition       71  
(b) Lipoxygenase inhibition       73 
(c) Xanthine oxidase inhibition      74 
      3.9.7 Determination of flavonoid compounds     75 
(a) Thin layer chromatography (TLC)                   75        
(b) UV-vis spectrophotometer       75 
(c) High performance liquid chromatography     76  
vii 
 
3.10 Toxicity test of T. lactinea extract        76 
   3.10.1 Yellow tetrazolium salt (MTT) assay procedure   76 
 
CHAPTER FOUR-RESULTS AND DISCUSSION 
4.1 Screening of an anti-inflammatory agent producing fungi via    79 
      flavonoid and enzyme inhibition assays. 
4.2 Optimization of culture conditions for growth and flavonoid   91  
      production by T. lactinea in shake flasks cultures    
      4.2.1 Optimization using one-factor-at-a-time (OFAT) method              92   
(a) Effect of media composition      92 
(b) Effect of initial pH        94 
(c) Effect of inoculum size       95 
           (d) Effect of incubation temperature      97 
           (e) Effect of incubation time       98 
      4.2.2 Optimization using Design of Experiment (DoE)    99 
      4.2.3 Statistical analysis and empirical model development            100 
      4.2.4 Effect of process variables on flavonoid production            104 
      4.2.5 Verification of proposed model               109 
4.3 Growth and flavonoid production of T. lactinea in stirred tank            110 
      bioreactor of batch mode        
      4.3.1 Effect of aeration rate                            110 
      4.3.2 Effect of agitation speed                           116 
      4.3.3 Effect of volumetric air flow rate and agitation              121
    on the morphology and rheology of T. lactinea 
      4.3.4 Effect of volumetric air flow rate and agitation speeds on                        123 
viii 
 
oxygen uptake rate (OUR), volumetric oxygen transfer coefficient (kLa)  
and oxygen transfer rate (OTR) in batch cultivation of T. lactinea  
in a stirred tank bioreactor. 
4.3.5 Effect of initial glucose concentration            125 
4.4 Growth and flavonoid production of T. lactinea in stirred tank          129 
      bioreactor of Fed Batch Mode        
4.5 Comparison of flavonoid production at different culture conditions         131 
      T. lactinea.  
4.6 Kinetics and modeling of growth, flavonoid production, glucose        132 
      consumption and inhibition by T. lactinea in a stirred tank  
      bioreactor (STB)         
      4.6.1 Selected model              132 
      4.6.2 Model analysis              137 
          (a) T. lactinea growth              137 
          (b) Flavonoid production             142 
          (c) Glucose utilization              147 
          (d) Glucose inhibition studies                        151 
4.7 The presence of flavonoid compounds from T. lactinea extract were            153 
determined using three types of analytical tools. 
(a) Thin layer chromatography (TLC) analysis         153 
(b) Spectrophotometric analysis           155 
(c) High performance liquid chromatography (HPLC) analysis                156 
4.8 Toxicity test               158 
 
 
ix 
 
CHAPTER 5- CONCLUSION AND RECOMMENDATIONS    
5.1 Conclusions             159 
5.2 Recommendation for future work           162 
 
REFERENCES             163 
 
APPENDICES          
Appendix A: Standard calibration curve          191 
Appendix B: Simulations of experimental data using Polymath       193 
Appendix C: Derivation of empirical model for fermentation kinetics      205 
 
LIST OF PUBLICATIONS            208 
  
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
LIST OF TABLES 
   
Table 2.1 Subclasses, structure and sources of flavonoids 
(Nijveldt et al., 2001; Agrawal, 2011; Kumar and 
Pandey, 2013). 
18 
Table 2.2 Choice of solvent for flavonoids extraction (Andersen 
and Markham, 2010) 
 
21 
Table 2.3 Optimization design approach for the maximum 
responses based on literatures 
 
38 
Table 2.4 Patterns of growth with regard to r value (Dhanasekar 
et al., 2003) 
 
44 
Table 2.5: Product formation patterns as indicated by α and β 
values (Shuler and Kargi, 2002). 
 
46 
Table 3.1 List of Chemicals 
 
56 
Table 3.2 List of equipment 
 
58 
Table 3.3 List of macrofungi used in this study 
 
60 
Table 3.4 Composition of different types of production media for 
growth and flavonoid production by T. lactinea in 
64 
xi 
 
shake flask cultures (Yang and Liau, 1998; Mashitah, 
2006) 
 
Table 3.5 Optimization of culture conditions for flavonoid 
production by T. lactinea in shake flask cultures using 
one-factor-at-a-time (OFAT) method 
 
65 
Table 3.6 Coded and actual values of selected variables on 
optimization of flavonoid production by T. lactinea 
using Box-Behnken design. 
 
65 
Table 3.7 Selected variables for bioreactor study 
 
67 
Table 3.8 Mobile phase for TLC analysis 
 
75 
Table 4.1 Flavonoid concentration in the fungi extract (µg/mL) 
using maceration and ultrasonic extraction method. 
 
81 
Table 4.2 Anti-inflammatory potential of selected fungi via 
enzyme inhibition assays. 
 
85 
Table 4.3 Composition of production media for growth and 
flavonoids production by T. lactinea in shake flask 
cultures (Yang and Liau, 1998; Mashitah, 2006) 
 
93 
xii 
 
Table 4.4 Coded and actual values of selected variables on 
optimization of flavonoid production by T. lactinea 
using Box-Behnken design. 
 
99 
Table 4.5 Experimental design matrix of four independent 
variables in actual values with experimental results 
 
101 
Table 4.6 Analysis of variance (ANOVA) of the regression 
model for flavonoid production 
 
103 
Table 4.7 Numerical optimization approach for flavonoid 
production 
 
109 
Table 4.8 The optimum condition proposed by Box Behnken 
design for flavonoid production 
 
110 
Table 4.9 Rheological data of T. lactinea culture broth at 
different agitation speed and volumetric air flow rate in 
stirred tank bioreactor of batch mode. 
 
122 
Table 4.10 Effect of volumetric air flow rate and agitation speed 
on oxygen uptake rate (OUR), volumetric oxygen 
transfer coefficients, kLa and oxygen transfer rate 
(OTR) in batch cultivation of T. lactinea in a stirred 
tank bioreactor of batch mode. 
125 
xiii 
 
 
Table 4.11 Selected kinetic model equations for growth, product 
formation and substrate utilizations used in the present 
study. 
 
134 
Table 4.12 Estimated model parameters for growth of T. lactinea 
in a stirred tank bioreactor at different initial glucose 
concentration based on: (a) Monod, (b) Logistic (c) 
Modified logistic and (d) Gompertz model. 
 
141 
Table 4.13 Estimated model parameters for the flavonoid 
production by T. lactinea in a stirred tank bioreactor at 
different initial glucose concentration based on: (a) 
Logistic incorporated Luedeking-Piret, (b) Modified 
logistic-incorporated Leudeking Piret, (c) Modified 
Gompertz, and (d) Monod-incorporated Leudeking-
Piret model 
 
146 
Table 4.14 Estimated model parameters for glucose utilization at 
different initial glucose concentration based on: (a) 
Logistic incorporated modified Luedeking-Piret, (b) 
Modified logistic-incorporated modified Leudeking-
Piret, (c) Modified Gompertz, and (d) Monod-
incorporated Leudeking-Piret. 
 
150 
xiv 
 
Table 4.15 Estimated parameters obtained from the different 
glucose inhibition models. 
 
152 
Table 4.16 Rf values of isolated rutin and rutin standard at 
different mobile phase. 
 
153 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF FIGURES 
   
Figure 1.1 Total number of ADR Reports Received Categorized 3 
xv 
 
by State (Source: Malaysian Adverse Drug Reactions 
Newsletter, May 2009) 
 
Figure 2.1 Basic structure of flavonoid compounds (Cushnie and 
Lamb, 2005) 
 
17 
Figure 2.2 Cell growth profile in batch culture (Rao, 2010) 32 
   
Figure 2.3 Growth curve (Zwietering et al., 1990) 
 
45 
Figure 3.1 Research methodology flow chart 
 
59 
Figure 3.2 The dynamic gassing-out method for kLa and OUR 
determination (García-Ochoa et al., 2000) 
 
69 
Figure 4.1 Effect of different types of medium composition on 
biomass and flavonoid production by T. lactinea in 
shake flask culture. Error bar indicated standard error 
for triplicates.  
 
92 
Figure 4.2 Effect of different initial pH of production media on 
biomass and flavonoid production by T. lactinea in 
shake flask culture. Error bar indicated standard error 
for triplicates.  
 
95 
xvi 
 
Figure 4.3 Effect of inoculum size on growth and flavonoid 
production by T. lactinea in shake flask culture. 
(Inoculum volume of 1, 5, 10, 20 and 30 ml is 
equivalent to inoculum size 2, 10, 20, 40 and 60 % v/v). 
Error bar indicated standard error for triplicates.  
 
96 
Figure 4.4 Effect of incubation temperature on growth and 
flavonoid production by T. lactinea in shake flask 
culture. Error bar indicated standard error for 
triplicates.  
 
97 
Figure 4.5 Effect of incubation time on growth and flavonoid 
production by T. lactinea in shake flask culture. Error 
bar indicated standard error for triplicates.  
 
98 
Figure 4.6 Predicted data from proposed model versus actual data 
of an experiment 
 
104 
Figure 4.7  Response surface plots for the (a) effect of pH and 
temperature (oC) and (b) pH and incubation time (day) 
on the flavonoid production (µg/mL) by T. lactinea. 
106 
 
 
Figure 4.8 
 
Response surface plots for the effect of (a) inoculum 
size 
 (% v/v) and temperature (oC) and (b) inoculum size (% 
 
108 
xvii 
 
v/v) and incubation time (day) on the flavonoid 
production (µg/mL) by T. lactinea. 
 
Figure 4.9 Effect of different volumetric air flow rate on (a) 
growth and (b) flavonoid production during batch 
cultivation of T. lactinea in a 2.5 L stirred tank 
bioreactor of batch mode and agitation at 100 rpm. 
Error bar indicated standard error for triplicates.  
 
113 
Figure 4.10 Effect of different volumetric air flow rate on (a) 
glucose concentration and (b) dissolved oxygen tension 
(% saturation) during batch cultivation of T. lactinea in 
a 2.5 L stirred tank bioreactor of batch mode and 
agitation at 100 rpm. Error bar indicated standard error 
for triplicates.  
 
115 
Figure 4.11 Effect of different agitation speed on (a) growth and (b) 
flavonoid production during batch cultivation of T. 
lactinea in a 2.5 L stirred tank bioreactor of batch mode 
and volumetric air flow rate at 1.0 vvm. Error bar 
indicated standard error for triplicates.  
 
110 
Figure 4.12 Effect of different agitation speed on (a) glucose 
concentration and (b) dissolved oxygen tension (% 
saturation) during batch cultivation of T. lactinea in a 
120 
 
xviii 
 
2.5 L stirred tank bioreactor of batch mode and 
volumetric air flow rate at 1.0 vvm. Error bar indicated 
standard error for triplicates.  
 
Figure 4.13 Log-log plot of viscosity versus shear rate (Condition: 
20 g/L of initial glucose concentration, 300 rpm, 1.0 
vvm). 
 
122 
Figure 4.14 Effect of different initial glucose concentrations on (a) 
growth and (b) flavonoid production during batch 
cultivation of T. lactinea in a 2.5 L stirred tank 
bioreactor of batch mode. Error bar indicated standard 
error for triplicates.  
 
127 
Figure 4.15 Effect of different initial glucose concentrations on (a) 
glucose concentration and (b) dissolved oxygen tension 
(% saturation) during batch cultivation of T. lactinea in 
2.5 L stirred tank bioreactor. Error bar indicated 
standard error for triplicates.  
 
128 
Figure 4.16 Effect of glucose feeding on T. lactinea growth and 
flavonoid production in a stirred tank bioreactor of fed 
batch mode.  
 
130 
 
Figure 4.17 Profile of glucose concentration fed every 12 hour in a 131 
xix 
 
stirred tank bioreactor of fed batch mode.  
   
Figure 4.18 Flavonoid production by T. lactinea extract at different 
culture conditions 
 
132 
Figure 4.19 Growth profiles of T. lactinea at different initial 
glucose concentration g/L) based on: (a) Monod model 
and (b) Logistic Model. 
 
138 
Figure 4.20 Growth profiles of T. lactinea at different initial 
glucose concentration g/L) based on: (a) Modified 
Logistic model and (b) Gompertz model. 
 
140 
Figure 4.21 Flavonoid production profiles of T. lactinea at different 
initial glucose concentration (mg/mL) based on: (a) 
Logistic incorporated Luedeking-Piret (LLP) model and 
(b) Modified logistic-incorporated Leudeking Piret 
(MLLP) model. 
 
143 
Figure 4.22 Flavonoids production profiles of T. lactinea at 
different initial glucose concentration (mg/mL) based 
on: (a) Modified Gompertz model and (b) Monod-
incorporated Leudeking-Piret model. 
 
145 
Figure 4.23 Glucose concentration profiles of T. lactinea at 148 
xx 
 
different initial glucose concentration (mg/mL) based 
on: (a) Monod incorporated modified Luedeking-Piret 
(MMLP) model and (b) Logistic incorporated modified 
Luedeking-Piret (LMLP) model.  
 
Figure 4.24 Glucose concentration profiles of T. lactinea at 
different initial glucose concentration (mg/mL) based 
on: (c) Modified logistic incorporated modified 
Leudeking-Piret model (MLMLP) and (d) Modified 
Gompertz model. 
149 
   
Figure 4.25 Comparison of specific growth rate for the 
experimental and glucose inhibition models at different 
initial glucose concentration.  
 
151 
Figure 4.26 Absorption of UV spectrum of isolated rutin (IR) and 
rutin standard (RS).  
 
155 
Figure 4.27 HPLC chromatograph of isolated rutin from aqueous 
extract of T. lactinea culture broth (Analysis condition: 
Mobile phase-acetonitrile: H2O (75:25 v/v), UV 
detection wavelength 280 nm, Mobile phase flow rate 
0.3 mL/min). 
 
156 
Figure 4.28 HPLC chromatograph of rutin standard (Analysis 157 
xxi 
 
condition: Mobile phase-acetonitrile: H2O (75:25 v/v), 
UV detection wavelength 280 nm, mobile phase flow 
rate 0.3 mL/min). 
 
Figure 4.29 Cell viability of Chinese hamster lung cells lines (V70-
4) at different dose of aqueous extract of T. lactinea 
culture broth. 
 
158 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF PLATES 
xxii 
 
   
Plate 3.1 Mycelial mat formed on MEA plate culture 
 
61 
Plate 3.2 Bioreactor experimental setup for (a) batch mode and 
(b) fed batch 
 
67 
Plate 4.1 TLC result of rutin isolated from aqueous extract of 
T. lactinea culture broth (SNDW) and rutin standard 
(RS) on TLC plate (Mobile phase: Ethyl acetate: 
ethanol (1:1). 
 
154 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF SYMBOLS 
xxiii 
 
 
α Product formation constant  
β Product formation constant  
σ Variance  
𝐴 Input variable – initial pH Day 
𝐵 Input variable – inoculum volume mL 
C Input variable-Incubation temperature  (oC) 
D Input variable-Incubation time day 
𝑑𝑋/𝑑𝑡 Growth rate   g/L.d 
𝐾𝑆  Substrate concentration at one – half the 
maximum specific growth rate 
g/L 
𝑚𝑆  Maintenance coefficient   g/g.d  
𝑛  Average cell count per square - 
𝑃𝑜  Product concentration at initial time µg/mL 
𝑃𝑡  Product concentration at any time µg/mL 
𝑆  Limited substrate concentration  g/L 
𝑆𝑜  Substrate concentration at initial time g/L 
𝑆𝑡  Substrate concentration gas at any time g/L 
𝑡  Time  hour 
𝑡𝑜  Initial time hour 
𝑋 Biomass concentration g/L 
𝑥𝑖  The level of independent variable - 
𝑥𝑗  Coded independent variable - 
𝑋𝑚  Maximum biomass g/L 
xxiv 
 
𝑥𝑚𝑎𝑥  Maximum value of the natural variable - 
𝑥𝑚𝑖𝑛  Minimum value of the natural variable - 
𝑋𝑜  Initial biomass g/L 
𝑌𝑋/𝑆  Biomass yield on the utilized substrate g X/g S 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF ABBREVIATIONS 
xxv 
 
ANN     Artificial neural network  
ANOVA    Analysis of variance  
BBD     Box-Behnken design  
CCD     Central Composite design  
DMSO    Dimetyl sulfoxide  
DNS     Dintrosalicyclic acid  
DO     Dissolved oxygen  
DoE     Design of experiment  
EPS     Exopolysaccharides  
FRIM     Forest Research Institute Malaysia   
GA     Genetic algorithm  
HPLC     High performance liquid chromatograph  
LLP     Logistic incorporated Luedeking-Piret  
L-M     Levenberg-Marquardt   
LMLP    Logistic incorporated Modified Luedeking-Piret  
MEA     Malt extract agar  
MLLP    Modified Logistic incorporated Luedeking-Piret   
MLMLP  Modified Logistic incorporated Modified Luedeking-
Piret  
MMLP    Monod incorporated Modified Luedeking-Piret  
MTT     3-(4,5-dimetylthylthiazolyl-2)-2,5-diphenyltetrazolium 
bromide 
OFAT     One-factor-at-a-time  
OTR     Oxygen transfer rate  
OUR     Oxygen uptake rate  
xxvi 
 
pO2    Partial dissolved oxygen concentration 
RMSD    Root mean square deviation  
RSM     Response surface methodology  
TLC    Thin layer chromatography 
UV    Ultraviolet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxvii 
 
PENGHASILAN FLAVONOID, IAITU AGEN ANTI-RADANG DARIPADA 
Trametes lactinea 
ABSTRAK 
Flavonoid adalah salah satu sebatioan bioaktif yang berharga dan mempunyai aktiviti 
farmakologi yang luas termasuk anti-radang. Pendekatan ke arah biologi yang mudah 
dan berkesan bagi menghasilkan flavonoid dari enam spesies tempatan yang telah 
dipencil dan diperolehi daripada pusat pengumpulan kultur telahpun dijalankan. 
Trametes lactinea telah didapati menghasilkan flavonoid tertinggi di dalam kaldu 
kulturnya, dan merencat aktiviti enzim anti-radang, iaitu hialuronidase dan 
lipoksigenase. Di dalam kultur kelalang goncang, kesan keadaan kultur ke atas 
biojisim dan penghasilan flavonoid oleh T. lactinea (komposisi medium, pH awalan, 
suhu dan masa eraman) telah dioptimum menggunakan kaedah satu-faktor-di-satu-
masa (OFAT). Keputusan menunjukkan biojisim tertinggi diperolehi dalam medium 
3 yang mempunyai glukosa, yis dan pepton. Bagaimanapun, medium ini tidak 
menggalakkan penghasilan flavonoid oleh kulat terpilih, tetapi lebih kepada medium 
yang mempunyai kandungan karbon dan mineral yang sedikit (Medium 2). Empat 
parameter terpilih yang diperolehi dari OFAT telah dioptimumkan lebih lanjut untuk 
penghasilan flavonoid dengan menggunakan kaedah sambutan permukaan (RSM) 
berdasarkan rekabentuk Box-Behnken. Empat parameter yang terlibat di dalam 
kajian ini ialah pH awalan, isipadu inokulum, suhu eraman dan masa eraman. 
Penghasilan flavonoid yang tinggi (20.02 µg/mL) telah diperolehi dalam medium 
penghasilan yang mempunyai pH awalan 6, suhu inkubasi 35oC dan masa inkubasi 
8.1 hari. Untuk penghasilan biojisim dan flavonoid yang tinggi, prestasi di dalam 2.5 
L bioreaktor tangki teraduk telah dikaji dengan mengambil kira kesan kadar 
pengudaraan (0.5 to 1.5 vvm), kelajuan pengadukan (100 to 300 rpm) dan awalan 
xxviii 
 
kepekatan glukosa (10-60 g/L). Biojisim dan penghasilan flavonoid tertinggi telah 
diperolehi pada kelajuan pengaduk 300 dan 100 psm, dan awalan kepekatan glukosa 
pada 40 dan 20 g/L. Lanjutan daripada itu, pekali pemindahan oksigen (kLa) oleh T. 
lactinea juga telah dikaji dengan mengambil kira kesan kadar pengudaraan dan 
kelajuan pengadukan. Keputusan menunjukkan nilai kLa meningkat dengan 
peningkatan kadar pengudaraan daripada 0.5 kepada 1.5 vvm, dan kelajuan 
pengadukan daripada 100 kepada 300 psm. Fermentasi secara suapan kelompok oleh 
T. lactinea di dalam bioreaktor tangki teraduk juga telah dijalankan, dan strategi 
glukosa suapan telah meningkatkan penghasilan flavonoid berbanding dengan di 
dalam mod kelompok dan kultur kelalang goncang. Kinetik untuk pertumbuhan, 
penghasilan produk, penggunaan and perencatan glukosa oleh kulat yang diuji telah 
juga diperhatikan. Untuk pertumbuhan kulat, model ‘Logistic’, model ‘Modified 
Logistic’ dan model ‘Gompertz’ adalah berpadanan dengan data eksperimen dengan 
nilai R2 > 0.98 dan RMSD <0.050 pada kepekatan glukosa 40 g/L. Model ‘modified 
Gompertz’ pula lebih  berpadanan dengan data eksperimen untuk penghasilan 
flavonoid dengan nilai R2 > 0.90 dan nilai RMSD yang rendah pada kepekatan 
glukosa 20 g/L. Untuk penggunaan dan perencatan glukosa, model modified 
Gompertz and model Luong telah memberikan padanan yang baik dengan nilai R2 
yang tinggi dan RMSD yang rendah. Rutin telah didapati di dalam ektrak akues T. 
lactinea apabila ianya dianalisa dengan menggunakan pelbagai jenis alatan analitis 
(TLC, UV-vis spectrophotometer and HPLC). Ujian ketoksikan menunjukkan ektrak 
akues T. lactinea ini tidakpun memberikan kesan ke atas sel warisan paru-paru 
“Chinese hamster (V79-4)” yang telah didedahkan selama 24 jam. 
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PRODUCTION OF FLAVONOID, AN ANTI-INFLAMMATORY AGENT 
FROM Trametes lactinea 
 
ABSTRACT 
 
Flavonoid is one of the remarkable bioactive compound that possesses broad 
pharmacological activities including anti-inflammatory. A simple and effective 
bioroute approach for the production of flavonoid by six locally isolated strain 
obtained from culture collection center were looked at. Trametes lactinea was found 
to produce the highest flavonoid in its culture broth and inhibited the anti-
inflammatory enzyme activities, hyaluronidase and lipoxygenase. In shake flask 
culture, the effect of culture conditions on biomass and flavonoid production by T. 
lactinea (media composition, initial pH, inoculum volume, temperature and 
incubation time) were optimized using one-factor-at-a-time (OFAT) method. Results 
showed that the highest biomass was obtained in the Medium 3, containing glucose, 
yeast and peptone. However, this production medium was not favourable for 
flavonoid production by the tested fungus but it preferred to condition of less carbon 
media with a small amount of minerals (Medium 2). Four selected parameters 
obtained in OFAT was further optimized for flavonoid production by T. lactinea 
using a Response Surface Methodology (RSM) coupled with Box Behnken design 
(BBD). Four parameters that involved in this study were initial pH, incubation 
temperature and incubation time. The highest flavonoid production (20.02 µg/mL) 
was obtained in the production media with initial pH 6, incubation temperature 35oC 
and incubation time 8.1 days, respectively. To achieve higher biomass and flavonoid 
production, the performance of 2.5 L stirred tank bioreactor was investigated by 
considering effect of aeration rates (0.5 to 1.5 vvm), agitation speed (100 to 300 rpm) 
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and initial glucose concentration 10 to 60 g/L). The highest biomass and flavonoid 
production were obtained at agitation speed 300 and 100 rpm, and initial glucose 
concentration at 40 and 20 g/L, respectively. The volumetric oxygen transfer 
coefficient (kLa) of T. lactinea was also studied by considering the effect of aeration 
rate and agitation speed. Results showed that kLa values increased with increased of 
aeration rate from 0.5 to 1.5 vvm and agitation speed from 100 to 300 rpm, 
respectively. Fed batch fermentations of T. lactinea in a stirred tank bioreactor was 
also conducted and the results showed that a glucose feeding strategy was favourable 
process that enhanced the flavonoid production compared to batch mode and a shake 
flask culture. Kinetics of growth, product formation, glucose utilization and 
inhibition of the tested fungus were also looked at. For T. lactinea growth, the 
Logistic, Modified Logistic and Gompertz models fitted well with the experimental 
data with R2 > 0.98 and RMSD <0.050 at initial glucose concentration at 40 g/L. The 
modified Gompertz model provided a more accurate description with R2 values > 
0.90 and smaller RMSD for the flavonoid production at initial glucose concentration 
at 20 g/L. For substrate utilization and inhibition, the modified Gompertz model and 
the Luong model described well the experimental data with high R2 and low RMSD 
values. Rutin was found in the aqueous extract of T. lactinea when analyzed using 
various analytical tools (TLC, UV-vis spectrophotometer and HPLC). Cytotoxicity 
test revealed that the aqueous extract of T. lactinea possessed no toxic effect towards 
Chinese hamster lung (V79-4) cell lines within 24 hour exposure. 
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CHAPTER 1 
INTRODUCTION 
1.1 Research background 
Inflammation is recognized as a major risk factor in human diseases (Pan et al., 
2010). Stoner and Wang (2013) reported that inflammation is caused by numerous 
factors such as oxidative stress, environmental pollutants, microbial agents, and physical 
damage to tissues. In classical features, inflammation was defined as redness, warmth, 
swelling, and pain (Gautam and Jachak, 2009). Basically, inflammation has its beneficial 
effect as it leads to removal of offending factors and restoration of tissue structure and 
physiological function (Ricciotti and FitzGerald, 2011). As the inflammation became 
uncontrolled and caused an extreme host cell damaged, the anti-inflammatory drugs 
such as glucocorticoids and aspirin were used to inhibit the enzymes (phospholipase A2 
and cyclooxygenase) that promoted the inflammatory pathways (Vane and Botting, 
1987).  
The history of anti-inflammatory agent started 3,500 years ago at a time when the 
Greek physician Hippocrates prescribed an extract from willow bark and leaves to treat 
fever and inflammation (Rao and Knaus, 2008). Later, the active ingredient of willow 
bark salicin was identified and improved by Felix Hoffman, who was working in Bayer 
Company which has become the most widely used medicines until today (Vane and 
Botting, 2003). The non-steroid anti-inflammatory drugs (NSAIDs) are heterogeneous 
group of compounds that possessed anti-inflammatory, analgesic, and antipyretic 
properties which including aspirin, ibuprofen, naproxen, indomethacin, celebrex and etc 
(Charlier and Michaux, 2003; Fendrick and Greenberg, 2009). 
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Nevertheless, utilization of these NSAIDs and other drugs in inflammation 
treatment was reported to produce unwanted side effects on human. In 2002, about 
30,000 cases of acetaminophen ingestion were reported to the American Association of 
Poison Control Centers with 110 deaths were due to acetaminophen ingestion (Watson 
et al., 2003; Bartlett, 2004). According to Dugowson and Gnanashanmugam (2006), the 
usage of non-selective NSAIDs can lead to the development of gastro duodenal ulcers 
four to eight times during therapy. In the United States, NSAIDs was reported to be used 
regularly at least by 13 million people with various arthritides. Out of that, 16,500 
NSAID-related deaths occurred among patients with rheumatoid arthritis or 
osteoarthritis every year in the United States (Wolfe et al., 1999). In fact, this number 
was greater than the number of deaths due to asthma, cancer and other diseases. On the 
other hand, there were also some of them, including Vioxx® and lumiracoxib 
(Prexige®) which were withdrawn from the market in 2004 and 2007 due to their side 
effects (Rao and Knaus, 2008).  
As for Malaysia, the Malaysia Adverse Drug Reactions Newsletter on May 2009 
stated that a total of 4826 local spontaneous reports of suspected adverse drug reactions 
(ADRs) were recorded in 2008. Number of reports has increased more than 90% since 
1987. Figure 1.1 showed that Selangor was the leading state reported on the adverse 
drug reaction followed by Wilayah Persekutuan (612) and Sabah. The newsletter also 
reported that the most number of suspected ADRs were attributed to the 
pharmacological group cardiovascular, and the suspected drug that contributed to the 
highest number of ADR reports was perindopril followed by aspirin and diclofenac. Due 
to that, demand for an alternative and safe anti-inflammatory preventive drug has 
become an urgent need today. 
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Figure 1.1: Total number of ADR Reports Received Categorized by the states of Malaysia (Source: Malaysian Adverse Drug 
Reactions Newsletter, 2009). 
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Over the millennia, utilization of natural products from plants, herbs, fruits, 
animals and fungi have played a significant role in human health. Indeed, it also made an 
enormous contribution in drug development. Wang et al. (2007) in their research stated 
that about 60% of antitumor/anti-infectious drugs that were already in the market or 
under clinical investigations were of natural origin. In fact, natural products and its 
derived drugs were well represented in the top 35 worldwide selling ethical drugs in 
2000, 2001 and 2002. Previously, Butler (2004) mentioned that the percentage of natural 
product-derived drugs was 40% in 2000 and remained approximately constant at 24% in 
2001, 26% in 2002 and significantly contributed to the profitability of many companies. 
These natural products were reported to have different chemical classes such as 
alkaloids, steroids, terpenoids, polyphenolics, flavonoids, phenylpropanoids, fatty acids 
and lipids, and various miscellaneous compounds which could inhibited the 
inflammatory cytokines and inflammatory mediators such as IL-1, IL-6, IL-10, TNF-a, 
NF-κB, NO, iNOS and COX-2 (Gautam and Jachak, 2009; Debnath et al., 2013). One of 
the remarkable active compounds in natural product is flavonoids, which naturally 
distributed in the plant kingdom. In plant, its function is as flower colorant, and the 
distribution between plant taxa has made the first move for researchers to study on these 
compounds, thus leading to its first documented article in the late 1960s. According to 
Winkel-Shirley (2001), besides providing beautiful colorant in leaves, flower, fruits and 
seeds, flavonoids also played its roles in male fertility of some species, signaling 
between plants and microbes, antimicrobial agents and feeding deterrents and UV 
protection.  
Flavonoids were known for their beneficial effects on health long before they were 
isolated as effective compounds (Nijveldt et al., 2001). Pan et al. (2010) reported that 
5 
 
flavonoid was a potent antioxidant and exhibited broad pharmacological activities 
including anti-inflammatory, antimicrobial, anti-viral, anti-bacteria and anti-
carcinogenic. In fact, the health benefit of products such as Ginkgo biloba containing 
natural-flavonoids (quercetin, kaempferol and isorhamnetin) has reached its annual sales 
more than USD 100 million worldwide in 1996 (Springen and Cowley, 1997). 
Nowadays, the usage of flavonoids compound has gone beyond nutritional supplements. 
The conjugated anthocyanins, such as cyanidin glucoside are used as natural colorants 
for flavor and fragrance industries. The unit price of cyaniding could reached up to USD 
600 /kg  (Springen and Cowley, 1997). 
The commercialization of flavonoids in a large-scale production platform becomes 
more important either for health related research or commercial nutritional applications. 
Previously, flavonoids compound are produced with two methods; chemical synthesis 
and isolation from plant (Koopman et al., 2012). Flavonoid produced from chemical 
synthesis need an extreme condition and used toxic chemicals such as 2', 4'-
Dihydroxyacetophenone and 2'-Hydroxy-5' methoxyacetophenone (Lim et al., 2001; 
Leonard et al., 2008). This method was seen uneconomic as it added to cost production 
when the effluent wastes need to go through the wastewater treatment. In fact, toxic 
solid wastes have created another disposal problem to the environment. Hence, it geared 
the researchers direction to isolate the flavonoids compound from the plants (Koopman 
et al., 2012).  
Various extraction techniques were widely investigated to extract valuable 
compounds from plant. Traditionally, soxhlet, hydrostillation and maceration with an 
alcohol–water mixture or hot fat were used to extract these compounds for 
commercialization (Wang and Weller, 2006). These extraction methods took several 
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hours and many solvent for the extraction process to be completed. Due to that, green 
extraction methods using ultrasonic and microwave were developed to overcome such 
issues and become the biggest challenge for researchers is to maintain the availability of 
flavonoids production from the plant (Hemwimol et al., 2006; Liazid et al., 2010). 
Nevertheless, the commercialization of flavonoids from plant species is not successfully 
applied due to low growth rate of the plants (Wang et al., 2011; Koopman et al., 2012).  
Again, it geared the researchers direction to approach metabolic engineering using 
microorganism such as Saccharomyces cerevisiae and E. coli to enhance higher value 
flavonoid products such as naringenin and pinocembrin (Chemler et al., 2006; Leonard 
et al., 2008). Four catalytic steps were involved for the conversion of the aromatic amino 
acid L-tyrinne to the main flavanone precursor, naringenin. In this process, the 
conversion of L-tyrosine to the phenylpropanoic acid p-coumaric acid go through the 
action of the enzyme tyrosine ammonia lyase (TAL). Once p-coumaric acid has been 
generated, 4-coumarate: CoA ligase (4CL) mediates the formation of its corresponding 
CoA ester, coumaroyl-CoA. This compound was subsequently condensed with three 
malonyl-CoA units by the sequential action of the type III polyketide synthase, chalcone 
synthase (CHS). The final step of this process resulting naringenin chalcone 
stereospecifically isomerized by chalcone isomerase (CHI) to form the (2S)-flavanone 
naringenin. Hence, discovery of this compound has become a starting point for the 
synthesis of varieties of other flavonoid molecules, which are created through the 
combined actions of functionalizing enzymes which hydroxylated, reduced, alkylated, 
oxidized, and glucosylated this phenylpropanoids core structure, accordingly (Kaneko et 
al., 2003; Fowler and Koffas, 2009; Santos et al., 2011). 
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However, Santos et al. (2011) stated that the approach of metabolic engineering 
using microorganism for the production of flavonoids has two major drawbacks: (1) the 
requirement for expensive phenylpropanoic (acid amino) precursors supplemented into 
the media, and (2) the need for two separate media formulations for biomass/protein 
generation and flavonoid production. Traditionally, the flavonoids fermentation protocol 
required two separation steps to achieve higher flavonoid titers. Strains were grown in 
rich media for biomass growth and adequate heterologous protein formation. After 
reaching a target density, cells were harvested and then transferred into minimal media 
supplemented with phenylpropanoic precursors for flavonoids production. These two 
separation steps of biomass seemed to be unrealistic in large scale of fermentation 
processes as it added to cost production. In fact, an expensive price of L-tyrosine, a 
flavonoid precursor (RM2500/kg-Sigma Aldrich) also attributed to this major drawback 
for commercialization. Then, medium formulation for flavonoids production was 
developed using two E. coli strains directly from glucose without phenylpropanoic 
precursors. They managed to produce 29 mg/l naringenin from glucose and up to 84 
mg/l naringenin with the additional of fatty acid inhibitor, cerulenin. This showed that 
although metabolic engineering is perceived to have a solution for higher flavonoids 
production, the need for fatty acid inhibitor in the process made it possible to reach an 
efficient and cost efficient production. Due to that, according to Wang et al. (2011) only 
few flavonoid compounds are being produced by fermentation at an industrial scale. 
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1.2 Problem statement 
Various physical and chemical methods have been used extensively on laboratory 
scale to produce flavonoids. The use of toxic chemicals and an extreme reaction 
conditions are of vital concern. In fact, commercialization of flavonoids from plant using 
established extraction techniques did not give much solution due to plant’s slow growth.  
The need of expensive flavonoid precursor in the metabolic engineering has also limited 
its production in large scale. 
Flavonoids were reported to be infrequent in fungi. However, Bird and Marshall 
(1969) had successfully isolated flavonoids compound, chlorflavonin (3’-chloro-5,2’-
dihydroxy-3,7&trimethoxy- flavone)  from cultures of Aspergillus candidus. Continuing 
research by Abou-Zaid et al. (1997) have isolated another two novel C-methylflavonols 
in the Colletotrichum dematium f. sp. epilobii cultures extract. Although there was no 
discussion on whether flavonoids might have originated from the nutrient medium, the 
results obtained from the research carried out indicated that flavonoids compound were 
biosynthesized de vono by the fungi (Bohm, 1998). According to Hyun et al. (2011), 
fungi as well as plant are able to synthesize phenylalanine via the shikimic acid pathway. 
This phenylalanine is used either for protein synthesis in plants or metabolized through 
the phenylpropanoid pathway. Phenylpropanoid metabolism involved the action of 
phenylalanine ammonia lyase (PAL) leads to the biosynthesis of a wide array of 
phenylpropanoid secondary products including flavonoids. In fact, the PAL activity was 
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detected in a few basidiomycetes, deuteromycetes and one ascomycete, Nectria 
cinnabarina (Bandoni et al., 1968; Vance et al., 1975; Hyun et al., 2011). 
Fungi are particularly useful producers of secondary metabolites from an industrial 
point of view, due to their high production level and extra cellular secretion, as well as 
the relative ease of cultivation (Jami et al., 2010; Coleman et al., 2011). In fact, fungi is 
known as the second secondary metabolites group producers after Actinobacteria with 
industrial application (Barreiro et al., 2011). The estimated number of macrofungi on 
Earth is 140 000 however only 700 species of them were reported to possess significant 
pharmacological properties (Wasser, 2002). Unfortunately, Malaysia is still poorly 
represented in this research field compared to China and Japan. Occupied with the 
richest fungi biota, Malaysia could be a good base for more extensive research in 
exploration and biological evaluation of natural products from fungi. 
Many papers have reported on the genera Ganoderma, Schizophyllum, Inonotus, 
Phellinus, Lentinus and Trametes for their medicinal properties. Wasser (2002) reported 
that macrofungi have been intensively investigated for medicinal effects in in vivo and in 
vitro model systems for almost 40 years. The medicinal effects including anti-
inflammatory, antioxidant, antimicrobial and anticancer ( Barros et al., 2007a; Koyama 
et al., 2008; Standish et al., 2008; Abah and Abah, 2010; Lu et al., 2010). However, 
comprehensive study on Trametes lactinea, a species belonging to the family of 
Polyporaceae which can possibly be used as a model organism for the production of 
flavonoids is still limited. 
Fungi fermentation can be influenced by both physical and chemical parameters. 
These including media composition, pH of medium, inoculum volume, incubation time 
and etc (Fazenda et al., 2008). However, the detailed study of these parameters on 
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flavonoids production by fungi is still scarce in literature. The techniques for 
experiments range from conventional one factor at a time (OFAT) to more appropriate 
statistical and mathematical tools in order to optimize the effect of selected parameters 
for fungi fermentation.  
Fermentation systems with a scalable method using stirred tank bioreactor were a 
promising device for better production strategies. According to Scragg (1991), such 
bioreactor was design with dual advantages; low capital and low operating cost. In fact, 
an efficient mixing, excellent mass transfer and foam breaker provide several advantages 
as compared to other type of bioreactors.  
In engineering point of view, kinetics and mathematical modelling makes possible 
applications of principles and practices in understanding the critical parameters that 
influences the fungi growth and product formation in batch systems. Meanwhile, the 
fed-batch mode strategies is anticipated to address the limitation and problems faced 
with the batch mode strategies of stirred tank bioreactor, thereby improving the fungus 
performance. Such conditions for flavonoid production has not been observed 
independently and a detailed answer let alone exploited. As such, greater focus is 
required in predicting flavonoid fermentation performance as a function of chemical and 
physical parameters and mathematical modeling related to it.  
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1.3 Research Objectives 
The main objective of this research is to use a white rot fungus, Trametes lactinea 
as a model organism for flavonoid production using batch and fed batch fermentation. 
Prediction of kinetic rate behavior by a series of phases in the fermentation process was 
also carried out. The extract from this fungus was analyzed for its compound and tested 
on its toxicity. The specific objectives of the research are: 
 
1. To screen six locally isolated macrofungi for their potential of producing anti-
inflammatory agent via flavonoid and in vitro enzyme inhibition assays. 
2. To optimize the culture conditions for growth and flavonoid production by Trametes 
lactinea (T. lactinea) using one-factor-at-one-time (OFAT) method and a statistical 
tool in shake flask cultures. 
3. To study the growth and flavonoid production by T. lactinea in a 2.5 L stirred tank 
bioreactor operated as batch and fed batch modes.  
4. To select and validate the kinetics models of T. lactinea growth, flavonoid 
production, substrate consumption and inhibition of batch process.  
5. To determine the flavonoid compounds presence in T. lactinea extract, and tested for 
its toxicity against Chinese hamster lung cell lines.  
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1.4 Scope of Study 
For preliminary studies, six locally isolated macrofungi (Trametes pocas, 
Trametes feei, Trametes lactinea, Pycnoporus sanguineus, Schizophyllum commune and 
Lentinus sajor cajo) were selected and screened for their capability of producing anti-
inflammatory agent, via flavonoids content and in vitro enzyme inhibition assays. The 
selected enzymes were hyaluronidase, lipoxygenase and xanthine oxidase. These 
enzymes were chosen as they were known to be involved in the inflammation such as 
asthma, gout and allergic (Brash, 1999; Kong et al., 2000; Samee et al., 2009).  
Optimization of process variables on growth and flavonoid production of the 
selected fungus were determined using one-factor-at- a-time (OFAT) method in shake 
flask cultivation. The selected independent parameters on the targeted responses were 
further optimized using a response surface methodology approach. In this work, Box 
Behnken design was used for the optimization for flavonoid production. 
The optimum condition of flavonoid production that was determined previously, 
was then studied in a stirred tank bioreactor (STB) of batch mode. Effect of different 
culture conditions such as agitation, aeration and initial glucose concentration was 
investigated. Fed batch fermentation was also performed to identify the significance of 
the process over the conventional batch mode fermentation. To describe the kinetics of 
flavonoid production in stirred tank bioreactor, different kinetic models for growth, 
product formation, substrate utilization and inhibition were selected. These models were 
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then validated using coefficient of determination (R2) and root mean square deviation 
(RMSD). The extracted compounds of flavonoid were determined and MTT (3-(4,5 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cytotoxicity test was carried out 
on its toxicity against Chinese hamster lung cells lines.  
1.5  Organization of the thesis 
There are five chapters in the thesis and each chapter describes the sequence of 
this research. 
Chapter One gives the introductory of this research. It starts with a brief 
introduction and overview of inflammation, anti-inflammatory drugs and medicinal 
remedies of natural products. This chapter also presents the problem statement, research 
objectives, and scope of study. 
Chapter Two provides literature review of this research. This includes history, 
sources, structures and biological activities of flavonoids. Optimization of culture 
conditions using statistical analysis, fermentation kinetic and models were also 
highlighted in detail. 
Chapter 3 describes the materials and methods applied in this research. This 
includes screening for the presence of flavonoid and optimization of process parameters 
in shake flask and stirred tank bioreactor (STB) either of batch or fed batch mode. The 
kinetics of growth and flavonoid production of batch mode and analytical procedures 
were also described in this chapter.  
Chapter 4 presents the results and discussion of experiments that were carried out, 
together with data analysis at various operating condition and process parameters. This 
chapter is organized into several main sections: determination of anti-inflammatory 
potential of the selected macrofungi via presence of flavonoids and enzyme inhibition 
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assays, fermentation of flavonoid in shake flask and stirred tank bioreactor either batch 
or fed batch mode. Optimization studies for the flavonoid was obtained using OFAT 
method and response surface methodology. The kinetics and modeling for the 
fermentation was also presented.  
Chapter 5 concludes the research. Recommendations for future research were also 
given highlighted.  
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Flavonoid, as anti-inflammatory agent 
Flavonoid have been consumed by humans for about 4 million years (Kumar and 
Pandey, 2013). They have wide biological properties that stimulate human health and 
reduce the risk of diseases. 
 
2.1.1 History of flavonoid production 
 Szent-Gyorgyi first isolated a metabolite from orange in 1936 and known as 
vitamin P (Renaud and de Lorgeril, 1992; Tapas et al., 2008). Later, this metabolite was 
claimed as flavonoid (Kumar and Pandey, 2013).  According to Groot and Rauen 
(1998), over 4,000 varieties of flavonoids have been identified. In fact, many members 
of flavonoid family possessed attractive colours and responsible for the brilliant shades 
of blue, scarlet, orange, etc, in flowers, fruits and leaves. 
As reported in the literature, flavonoids are ubiquitously distributed in plant 
kingdom, which in attached to sugars (glycosides), although occasionally they are found 
as aglycones (Ross and Kasum, 2002; Lin and Weng, 2006; Tapas et al., 2008). 
According to Nijveldt et al. (2001), research on flavonoids have received great attention 
after discovery of the French paradox, ie, the low cardiovascular mortality rate observed 
in Mediterranean populations in association with red wine consumption and a high 
saturated fat intake.  
According to Andersen and Markham (2010), in the early 1960s, flavonoids were 
only viewed as metabolic waste products that were stored in the plant vacuole. In fact, 
flavonoids were reported can be found in only plant kingdom. However, a few years 
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later, there were reports stated the presence of flavonoids in mosses and liverworts and 
even their occurrence in an alga. Meanwhile, the presence of flavonoid compounds were 
also reported in fungi species (Abou-Zaid et al., 1997). Barros et al. (2007) stated that 
flavonoids were found as one of the major component in the methanolic extracts of 
Portuguese wild edible mushrooms (Lactarius deliciosus, Sarcodon imbricatus). 
However, detailed study of flavonoids producing fungi were very scarce in literature 
compared to flavonoids producing plant. Most of the works that were carried out only 
reported the presence of flavonoids in the fungal extract without any detail discussion on 
the flavonoids subclasses or compounds that were successfully produced or isolated in 
the fungal extract.  
Flavonoids are very important for human health. According to the US Department 
of Agriculture (USDA), flavonoids are consumed by human from foods. Flavonoids can 
be obtained in fruits, nuts and vegetables such as parsleys, tomatos, pears, strawberries, 
oranges, black beans and etc. The interest in the possible health benefits of flavonoids 
has increased owing to their potent antioxidant and free-radical scavenging activities 
observed in vitro (Ross and Kasum, 2002). In fact, flavonoids compound such as 
quercetin, kaempferol, morin, myricetin and rutin were reported acting as antioxidants 
and exhibited beneficial effects such as anti-inflammatory, anti-allergic, anti-viral, as 
well as anti-cancer activities (Tapas et al., 2008). Previously, studies carried out by 
Knekt et al. (2002) revealed that higher intake of quercetin caused lower mortality from 
ischemic heart disease, lung cancer incidence and asthma incidence. While, risk 
cerebrovascular disease was lower due to higher intakes of kaempferol, naringenin and 
hesperetin. Hence, indicated that flavonoid do cause good to human being.  
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2.1.2 Structure of flavonoid 
Based on the US Department of Agriculture (USDA), there are more than 5000 
flavonoid compounds with dietary flavonoids consisted of five subclasses of monomeric 
flavonoids (flavonols, flavones, flavanones, flavans and anthocyanidins), polymeric 
proanthocyanidins and isoflavones. According  to a few researchers, the basic structural 
feature of flavonoid compounds was the 2-phenyl-benzo[α]pyrane or flavane nucleus, 
which consisted of two benzene rings (A and B) linked through a heterocyclic pyrane 
ring (C) (Figure 2.1) (Brown, 1980; Cushnie and Lamb, 2005) Flavonoids can be 
divided into various classes on the basis of their molecular structure (Nijveldt et al., 
2001). Six major flavonoids subclasses are summarized in Table 2.1. As mentioned by 
Middleton et al. (2000), this subclasses was primarily based on the presence (or absence) 
of a double bond on position 4 of the C (middle) ring, the presence (or absence) of a 
double bond between carbon atoms 2 and 3 of the C ring, and the presence of hydroxyl 
groups in the B ring. Example, most of the flavonoid structure have a phenyl group 
substituted at the 2nd -position of the pyrone ring. As for isoflavonoids, the substitution 
occurred at the 3rd -position (Table 2.1). Uniquely, flavonoids also shared the common 
structure with tocopherols (vitamin E), the chromane ring (Middleton et al., 2000). 
 
Figure 2.1: Basic structure of flavonoid compounds (Cushnie and Lamb, 2005). 
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Table 2.1: Subclasses, structure and sources of flavonoids (Nijveldt et al., 2001; 
Agrawal, 2011; Kumar and Pandey, 2013). 
Group of 
flavonoids and its 
structure backbone 
Examples Sources 
Flavones
   
  
Apple skins, 
berries, broccoli, 
celery, olives, 
onions, grapes, 
parsley 
Flavonols 
   
Apple, berries, 
broccoli, onions 
Flavanones 
 
 
Citrus fruits 
Citrus peel 
Isoflavones 
 
  
 
Soybeans, soy 
foods, legumes 
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Continue…. 
Group of 
flavonoids and its 
structure backbone 
Examples Sources 
Flavan-3-ols 
   
Red wine, 
Tea 
Anthocyanidins 
  
 
Tea, 
strawberries, 
cherries, 
grapes 
 
 
2.1.3 Chemical and Physical Properties of flavonoid 
Most flavones and flavonols exhibited two major absorption bands: Band I (320–
385 nm) represented the B ring absorption, while Band II (250–285 nm) corresponded to 
the A ring absorption (Yao et al., 2004; Kumar and Pandey, 2013;). On the other hand, 
the functional groups attached to the flavonoid skeleton might caused a shift in 
absorption such as from 367 nm in Kaempferol (3,5,7,4’-hydroxyl groups) to 371 nm in 
quercetin (3,5,7,3’, 4’-hydroxyl groups) and to 374 nm in myricetin (3,5,7,3’, 4’, 5’-
hydroxyl groups). The absence of a 3-hydroxyl group in flavones distinguished them 
from flavonols. Hence, Band I always absorbed at a shorter wavelength by 20–30 nm, 
such as the 337 nm required for apigenin (Rice-evans et al., 1995; Rice-Evans et al., 
1996; Rice-Evans et al., 1997; Yao et al., 2004). As for flavanones, it have a saturated 
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heterocyclic C ring, with no conjugation between the A and B rings, as determined by 
their UV spectral characteristics (Rice-Evans et al., 1996). Meanwhile, flavanones 
exhibit a very strong Band II absorption and maximum between 270 and 295 nm, 
namely, naringenin-288nm and taxifolin-285 nm, and only a shoulder for Band I at 326 
and 327 nm. According to Yao et al. (2004), Band II appeared as one peak (270 nm) in 
compounds with a monosubstituted B ring, but as two peaks or one peak (258 nm) with 
a shoulder (272 nm) when a di-, tri-, or o-substituted B ring was present. As for 
anthocyanins, the compounds show distinctive Band I peak in the 450–560 nm region 
due to hydroxyl cinnamoyl system of the B ring, and Band II peaks in the 240–280 nm 
region due to the benzoyl system of the A ring. In fact, the colour of the anthocyanins 
varied with the number and position of the hydroxyl groups (Wollenweber and Dietz, 
1981; Yao et al., 2004). Yao et al. (2004) in their research revealed that the chemical 
structure and relative orientation of various moieties in the flavonoids molecule greatly 
influenced their biochemical and metabolites properties. 
 
2.1.4 Separation and quantification of flavonoid 
Flavonoids especially glycosides can be degraded by enzyme action when the 
material is fresh (wet). Due to that Andersen and Markham (2010) suggested that the 
material should be dried and in powdered form before proceeding to the extraction 
process. In flavonoids extraction, the polarity of solvent used is very important. Table 
2.2 listed choice of solvent used for flavonoids extraction. 
Table 2.2 Choice of solvent for flavonoid extraction (Andersen and Markham, 2010) 
Flavonoids Solvent 
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Less polar 
Isoflavones, 
flavanones, 
methylated flavones, 
flavonols 
 
Chloroform, dichloromethane, diethyl ether, or 
ethyl acetate 
Polar 
Flavonoids glycosides,  
more polar aglycones 
 
Alcohols or alcohol-water mixtures 
 
 
Traditionally, soxhlet extraction and maceration were used for many years in 
flavonoids extraction. In this extraction, hexane was firstly used to remove lipids 
followed by ethyl acetate or ethanol to obtain phenolics compound (Andersen and 
Markham, 2010).  However, these techniques need longer time and consumed a lot of 
solvent such as hexane that caused harmful effects on human and environment (Bimakr 
et al., 2013). Due to that green extraction technology using ultrasound-assisted 
extraction (UAE), microwave-assisted extraction (MAE), supercritical fluid extraction 
and accelerated solvent extraction (ASE) were developed to overcome such issue (Wang 
and Weller, 2006).  
In another study by Veličković et al. (2007), flavonoids were extracted from 
Salvia officinalis L and Salvia glutinosa L using ultrasonic method within 20 min 
compared to maceration technique that completed after 6 hours. The flavonoids 
composition depend on the tested species, the polarity of the extracting solvents and the 
extraction techniques applied. On the other hand, the smaller solvent volume, 0.5 mL 
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and extraction time 5 min for extraction of fungal metabolites using ultrasonic was 
recorded by Smedsgaard (1997). In fact, the concentration of these extracts was 
sufficient to determine all the secondary metabolites presence using a HPLC. 
As for supercritical fluid extraction (SFE), the technique relied on the solubilizing 
properties of supercritical fluids and ideal for the extraction of diffusion controlled 
matrices, such as plant tissues (Andersen and Markham, 2010). In another study by 
Dean et al. (1998), methanol was added as a modifiers for flavonoids extraction.  
  
2.1.5 Anti-inflammatory assays of flavonoid 
The significant contribution of enzyme inhibition assays is a basis of drug action 
which cannot be overestimated as this is demonstrated by the therapeutic benefits of 
classical examples of enzyme-inhibitory drugs such as penicillin, sulfonarnides, 
physostigmine, digitalis, methotrexate, and aspirin (Kalman, 1981). Flavonoids are 
known to inhibit a number of enzymes such as lipoxygenase, hyaluronidase, nitric oxide 
and cyclooxygenase-2, xanthine oxidase, lipases and etc (Havsteen, 1983; Wang et al., 
1994;  Raso et al., 2001; Kim et al., 2005). Maeda et al. (1990) claimed that inhibition 
of hyaluronidase activity can also be used to evaluate the anti-allergic reaction. A study 
carried out by Wang et al. (1994) revealed the capability of flavonoids to inhibit human 
preadipocyte aromatase which caused breast cancer. Meanwhile, the ability of 
flavonoids to inhibit acid arachidonic acid metabolite, leukotrienes C4 and D4 was 
reported by Ban et al. (1989). These metabolites is initiated by the reaction of 
arachidonic acid with 5-lipoxygenase enzyme and caused constriction in blood vessel 
and enhanced vascular permeability. In fact, Pidgeon et al. (2007) suggested that 
lipoxygenase inhibitors might lead to the design of biologically and pharmacologically 
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targeted therapeutic strategies inhibiting lipoxygenase isoforms and/or their biologically 
active metabolites, thus might be useful in cancer treatment.  
On the other hand,  Zhu et al. (2004) have reported on the inhibition of xanthine 
oxidase by Biota orientalis extract. This species is rich in flavonoids compound such as 
quercetin and rutin. They observed that no hypouricemic effect in the mouse liver which 
could be due to inhibition of xanthine oxidase activities by these flavonoids compound. 
Meanwhile, apigenin and quercetin (0.5–50 M) were found to be the most potent 
inhibitors of nitric oxide (NO) production and markedly decreased prostaglandin E2 
(PGE2) release and cyclooxygenase-2 (COX-2) expression in a concentration-dependent 
manner (Raso et al., 2001). 
 
2.2 White rot fungi 
2.2.1 Morphology of white rot fungi and their applications in food and pharmaceutical 
industries, and environmental. 
 
White rot fungi is defined as a group of fungi that degrade the brown colored 
lignin, leaving the white cellulose and giving the wood a bleached or pale appearance 
and transforming it into a fibrous mass that crumbles with a blow (Maheswari, 2012). 
According to Hickman et al. (2011), many wood rot fungi can be identified by the 
distinctive shape, color, and texture of the fruiting bodies that form on trees. These 
structures, called conks or brackets, often are located around wounds in bark, at branch 
scars, or around the root crown. Some decay fungi such as Armillaria mellea produce 
typical, fleshy, mushroom shaped fruiting bodies at the base of infected trees after a rain 
in fall or winter. Some fruiting bodies such as Armillaria mushrooms are annual (i.e., 
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they appear soon after the beginning of seasonal rains), but many are perennial and grow 
by adding a new layer each year. 
It is widely distributed in nature and grown rapidly under the warm and moist 
conditions of tropic climates, made Malaysia an ideal place for many fungi to flourish. 
They can be classified into categories of edible, medicinal and poisonous species. 
According to Salmiah (1997), white rot fungi is a mesophilic and thermophilic 
microorganisms that produced cellulase, laccase and lignase enzymes. These enzymes 
are used to digest the component of wood cell walls. It broke down lignin and cellulose 
and commonly caused rotted wood to feel moist, soft, spongy, or stringy and appear 
white or yellow (Hickman et al., 2011). Most of common white rot fungi are 
Ganoderma applanatum, Pycnoporus sanguineus, Schizophyllum commune, Lentinus 
sajor-caju, Trametes feei and Trametes versicolor and etc. In fact, these fungi has 
significantly revealed their enormous potential in human health as a source of nutritive 
food, pharmaceutical industries and also playing a role in controlling environmental 
(Salmiah, 1997; Miles and Chang, 2004).  
Rich in proteins and other individual nutrition such as fat, phosphorus, iron, and 
vitamins including thiamine, riboflavin, ascorbic acid, ergosterol, and niacin made edible 
white rot fungi such as Schizophyllum commune, Lentinus sajor-caju and P. ostreatus as 
a good source of nutritious food (Garcha et al., 1993; Salmiah, 1997; Bonatti et al., 
2004; Miles and Chang, 2004). This can be explained by the dramatic elevation of total 
worldwide cultivated mushroom production which is 0.90 million tons in 1975; to 6.16 
million tons in 1997 (Miles and Chang, 2004). 
Extensive research carried out by several researchers revealed that white rot fungi 
is a powerful lignin degrader (Wu et al., 2005). Lignin and its derivatives are one of the 
